UNSPSC 51342308: Valganciclovir

This classification denotes a purine antagonist and antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCU97FKN3R. European Medicines Agency schedules Valganciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00007MIG. Valganciclovir generally arises in the molecular formula C14H22N6O5.

UNSPSC 51342308 Valganciclovir is a Commodity code capturing pharmaceutical products procured by state and local health agencies, though the recent opportunities recorded under this code do not align with its nominal scope — the posted solicitations involve naloxone, doxycycline hyclate, and ciprofloxacin hydrochloride rather than valganciclovir itself. State and local health departments and county health authorities use codes in this family to procure prescription pharmaceuticals through competitive bid and piggyback arrangements, often leveraging cooperative purchasing consortia such as MMCAP Infuse to aggregate demand and secure volume pricing. The Illinois Department of Public Health and Seminole County, Florida represent the issuing bodies active under this code in recent months. Procurement vehicles include Invitations for Bid with fixed terms typically ranging from 12 months to two years, often with renewal options, and delivery is generally required to county health facilities or emergency services distribution points with quarterly or as-needed replenishment schedules.

Recent activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 three-year pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through MMCAP Infuse in August 2026 (Solicitation 26482DPHPREPDB53392) for doxycycline hyclate and ciprofloxacin hydrochloride supply. Seminole County, Florida issued an IFB (IFB60459723LAS) with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and vendor responsibility for all shipping costs. Neither opportunity specified Business Enterprise Program set-asides or domestic product preferences. The mismatch between the code's nominal pharmaceutical product and the actual solicitations recorded suggests either data classification drift or that this code captures a broader pharmaceutical procurement family than its specific drug name implies.